Search

Copyright of Canadian Journal of Veterinary Research / Revue Canadienne de Recherche Vétérinaire is the property of Canadian Veterinary Medical Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Background Objectives Methods Results Conclusions and Clinical Importance Stenting has become popular to treat tracheal collapse in dogs, but complications might arise and negatively affect treatment outcome.Determine the overall prevalence of complications of tracheal stenting in dogs.A bibliographic search was performed of publications from 2000 to 2020. Studies were assessed for quality of evidence and measured prevalence of the 8 most commonly reported complications after tracheal stenting in dogs (stent fracture, stent migration, relapsing collapse, granuloma formation, tracheobronchial infections, and early, late, and clinically relevant late cough). Random effects meta‐analyses were used to estimate pooled complications prevalence.Fifteen studies met inclusion criteria. Cough (early: 99%; 95% confidence interval [95% CI]: 95%–100%, late: 75%; 95% CI: 63%–85%, and clinically relevant: 52%; 95% CI: 42%–61%), tracheobronchial infections (24%; 95% CI: 14%–35%), and granulomas (20%; 95% CI: 11%–30%) were common after tracheal stenting. Stent fractures (12%; 95% CI: 5%–20%), relapsing collapse (10%; 95% CI: 5%–15%), and stent migration (5%; 95% CI: 1%–9%) were less frequent. Significant heterogeneity among studies was identified for the estimated prevalence of stent fracture, granulomas, infections, and late cough.Tracheal stenting in dogs is associated with a high risk of coughing and a moderate risk of tracheobronchial infections and granuloma formation. Because most complications will impact a dog's quality of life, owners must be informed that tracheal stenting is a second‐line procedure that does not necessarily alleviate the need for medical treatment and frequent follow‐up visits. Additional studies are warranted to identify the risk factors of these complications. [ABSTRACT FROM AUTHOR]

Objective: To compare the use of the video telescope operating monitor (VITOM) and use of a conventional unassisted surgical method for treatment of cervical intervertebral disc herniation in dogs., Animals: 39 dogs with cervical intervertebral disc disease., Methods: Prospective study. Dogs were prospectively nonrandomly assigned to either the VITOM (n = 19) or conventional surgery (20) group depending on VITOM system availability. Signalment and preoperative neurologic status were recorded for all dogs. Preoperative and postoperative CT myelography was performed to compare intervertebral space location, spinal cord dimensions at the decompression level, ventral slot dimensions, and residual disc material. Surgical complications and postoperative neurologic outcomes were recorded. Data were compared between the 2 groups using fixed-effects or mixed-effects models to consider double reading of CT myelography images., Results: No significant differences were noted between the 2 groups regarding the decompression ratio (P = .85), vertebral length body ratio (P = .13), ventral slot width ratio (P = .39), residual disc material (P = .30), and sinus bleeding (P = .12). No significant differences were found between the 2 groups regarding postoperative neurologic grade (P = .17)., Clinical Relevance: VITOM-assisted ventral slot decompression is equivalent to conventional surgery in treatment of cervical intervertebral disc herniation in dogs. The use of VITOM remains a good alternative to the conventional surgical method.

Objective: To describe the H-pharyngoplasty procedure, report the outcomes of dogs with brachycephalic obstructive airway syndrome (BOAS) treated with ala-vestibuloplasty and H-pharyngoplasty with a CO2 laser, and identify prognostic factors., Animals: 423 dogs., Procedures: Medical records of dogs admitted for BOAS from 2011 to 2017 were reviewed. Dogs were included if they were treated with ala-vestibuloplasty and H-pharyngoplasty with a CO2 laser. Signalment, physical examination findings, grades at admission of clinical signs associated with respiratory and digestive systems, diagnostic test results, postoperative treatments, and short-term follow-up results were extracted from medical records. Long-term follow-up of > 12 months was evaluated via questionnaire. Generalized ordered logistic regression was used for bivariable and multivariable analyses., Results: Overall mortality rate was 2.6%. Median duration of follow-up was 36 months (12 to 91 months), and 341 (80.6%) dog owners completed the questionnaire. Major complications included respiratory distress (2.1%), heatstroke (0.5%), and bronchopneumonia (0.5%). No dogs required revision surgery. Improvement in signs associated with the respiratory and digestive systems was reported in 72% and 34% of the dogs, respectively, and owners' satisfaction was high (97.1%). Risk of death increased by 29.8% (95% CI, 11.8% to 50.7%) for every 1-year increase in age., Conclusion and Clinical Relevance: H-pharyngoplasty was possible in all dogs with BOAS, including those previously treated with conventional surgery and was associated with low morbidity and improved respiratory and digestive signs. H-pharyngoplasty combined with ala-vestibuloplasty may be an alternative treatment for even the most severely affected dogs.